FDA slaps St. Jude Medical with warning letter

January 14, 2013 by MassDevice staff

St. Jude Medical says the FDA hit it with a warning letter last week over problems at the Sylmar, Calif., plant that makes its next-generation Durata defibrillator leads.

St. Jude Medical warning letter

St. Jude Medical (NYSE:STJ) said today that the FDA slapped it with a warning letter over problems with the Sylmar, Calif., plant where its keystone Durata defibrillator leads are manufactured.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp